|
|
| July 1, 2009: Drs. Harrington and Gibson discuss the clinical implications of vulnerable plaque and arterial wall remodeling on CTA |
In this edition of The Take Home Message, Dr. Robert Harrington and Dr. C. Michael Gibson
discuss the clinical implications of vulnerable plaque and arterial wall remodeling on CT
Angiography.
Disclosures for Dr. Gibson:
Present Research/Grant Funding
Abbott; Angel Medical Corporation; Astra Zeneca; Atrium Medical Systems; Baxter; Bayer
Corp. Cardica, Inc.; FibroGen, Inc.; Fold Rx; Genentech, Inc.; HeartScape Technologies;
INO Therapeutics, Inc.; Johnson & Johnson Corporation; Lantheus Medical Imaging;
NewCardio, Inc.; Portola Pharmaceuticals; Sanofi-Aventis; Schering Plough Corporation
Speakers Bureau
Daiichi Sankyo Company, Inc; Eli Lilly and Company; Glaxo SmithKline; Schering Plough
Corporation; The Medicines Company
Consultant
Acusphere, Inc.; Angel Medical Systems; Archemix Corporation; Ascenta Therapeutics Atrium
Medical Corporation; Bayer Corporation; Cardica Inc.; Heartscape Technologies, Inc.; ICON
Medical Imaging; Jim Moran Heart and Vascular Research Institute; John & Johnson
Corporation; Medicure, Inc.; Novartis Pharmaceutical Corporation; Portola Pharmaceuticals,
Inc.; Sanofi-Aventis Pharmaceuticals; Schering Plough Corporation; St. Jude Medical; The
Medicines Company
Stock Ownership
My wife owns stock in HealthMarx Inc.
Royalties as a Contributor
UpToDate in Cardiovascular Medicine; Pocket Medicine
Past Research/Grant Funding/Past Speakers Bureau/Past Consulting
ActivBiotics, Inc.; Acusphere, Inc.; Ascenta Therapeutics, Inc; Astra; Atrium Medical
Corporation; Bard Corporation; Biogen IDEC; Boston Scientific Corporation; Bristol Meyers
Squibb Company; British Biotech, plc.; CardioKinetix, Inc.; Ciba Geigy Corporation; COR
Therapeutics; Corgentech, Inc.; DVI Guidant Corporation; Eli Lilly and Company; Genentech,
Inc.; GlaxoSmithKline; INO Therapeutics, LLC; KAI Pharmaceuticals; Merck & Co., Inc.;
Millennium Pharmaceuticals; Momenta Pharmaceuticals; NIH; Novartis Corporation; Nuvelo;
PDL Pharmaceuticals; Percusurge, Inc.; Pfizer; Point Biomedical Corporation; Portola
Pharmaceuticals, Inc.; Sanofi-Aventis Corporation; Smith Kline Beecham; Sonus; St. Jude
Medical; The Medicines Company; timi3 Systems, Inc.
[ Download video ] |
|
No comments have been submitted
|